The E4 Expo in Dallas Highlights the Resurgence of the Regional Trade Show

The E4 Expo in Dallas has occurred for the past 12 years, but this year it will be earmarked as the industry’s first true hybrid event. Melody Craigmyle, Vice President of Marketing & Communication at Almo Corporation, spoke with MarketScale Host Ben Thomas about what the Expo will entail.

The Expo will include extensive interaction compared to typical online event sessions. Events catered toward individuals’ specific interests will include a digital signage tour, a DVLED tour, a new products tour, and more. “It’s insightful people doing meaningful interviews digging into the technology and helping them understand how it fits into applications,” Craigmyle elaborated.

Perhaps the most thrilling aspect of this year’s Expo involves a stimulating product experience. Craigmyle revealed that there will be live holograms onstage. One presenter from California and one from Washington, D.C. will appear to present the holograms.

Holograms have widespread application potential for the future because they allow someone who cannot physically attend an event to present onstage from their office desk. The applications are endless, from corporate settings to houses of worship to the education sector.

Craigmyle explained, “Imagine being able to bring in the best and brightest instructors, or physicians, or researchers into your university without them having to travel but to be there with the students either in person or online and then having access to such amazing professionals. Those are just some things people that I think people can start dreaming about in the pro AV industry.”

Other partners presenting products include Absen, Harman, Huddly, Jabra, Barco, and Son, which will feature a Whisper Suite.

Craigmyle believes the 2021 E4 Expo will help attendees grasp what a hybrid workplace is about while bringing whole solutions together at the event. Join Marketscale as they cover the event onsite this coming Tuesday, November 30.

More Stories Like This:

Touchless Meetings & Cloud-based AV Ecosystems at InfoComm 2021

Remote Work Made Microsoft Teams a Household Name. It Also Forced the Software to Adapt.

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More